Critical Contrast: Jupiter Wellness (JUPW) and Its Peers

Jupiter Wellness (NASDAQ:JUPW – Get Rating) is one of 27 publicly-traded companies in the “Toilet preparations” industry, but how does it contrast to its rivals? We will compare Jupiter Wellness to similar companies based on the strength of its valuation, profitability, institutional ownership, analyst recommendations, earnings, risk and dividends.

Profitability

This table compares Jupiter Wellness and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jupiter Wellness	-206.26%	-189.51%	-118.18%
Jupiter Wellness Competitors	-22.62%	10.28%	-6.84%

Valuation & Earnings

This table compares Jupiter Wellness and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Jupiter Wellness	$6.20 million	-$15.22 million	-0.66
Jupiter Wellness Competitors	$4.31 billion	$293.78 million	37.49

Jupiter Wellness’ rivals have higher revenue and earnings than Jupiter Wellness. Jupiter Wellness is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

14.1% of Jupiter Wellness shares are owned by institutional investors. Comparatively, 41.8% of shares of all “Toilet preparations” companies are owned by institutional investors. 32.9% of Jupiter Wellness shares are owned by company insiders. Comparatively, 21.3% of shares of all “Toilet preparations” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Jupiter Wellness and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jupiter Wellness	0	0	0	0	N/A
Jupiter Wellness Competitors	132	1029	1158	26	2.46

As a group, “Toilet preparations” companies have a potential upside of 17.46%. Given Jupiter Wellness’ rivals higher possible upside, analysts clearly believe Jupiter Wellness has less favorable growth aspects than its rivals.

Volatility and Risk

Jupiter Wellness has a beta of 0.21, suggesting that its share price is 79% less volatile than the S&P 500. Comparatively, Jupiter Wellness’ rivals have a beta of 33.68, suggesting that their average share price is 3,268% more volatile than the S&P 500.

Summary

Jupiter Wellness rivals beat Jupiter Wellness on 9 of the 10 factors compared.

Jupiter Wellness Company Profile

(Get Rating)

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.